stockportfolio.pro
LB Pharmaceuticals Inc (LBRX)
Healthcare · Biotechnology · NasdaqGM
LB Pharmaceuticals Inc revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Gross profit | — | — | — | — |
| Net income | $-14.35M | $-6.28M | $-63.10M | $-25.20M |
| Net margin | — | — | — | — |
Source: LB Pharmaceuticals Inc SEC filings (10-K).
Explore 4 years of LB Pharmaceuticals Inc financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track LBRX in your portfolio →
LB Pharmaceuticals Inc financial history by metric
About LB Pharmaceuticals Inc
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
LB Pharmaceuticals Inc — frequently asked questions
What is LB Pharmaceuticals Inc's revenue?
LB Pharmaceuticals Inc (LBRX) reported revenue of $0 for fiscal year 2025, according to its SEC filings.
Is LB Pharmaceuticals Inc profitable?
No — LBRX reported a net loss of $-25.20M in fiscal 2025.
What is LBRX's P/E ratio?
LB Pharmaceuticals Inc trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How much debt does LB Pharmaceuticals Inc have?
As of fiscal year 2025, LBRX carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is LB Pharmaceuticals Inc's market cap?
LB Pharmaceuticals Inc (LBRX) has a market capitalization of about $817.71M, based on the latest data in our nightly-refreshed cache.
When does LB Pharmaceuticals Inc's fiscal year end?
LBRX's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from LB Pharmaceuticals Inc's official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.